Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for COPD Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01713075

Enrollment

1183

Registered

2012-10-24

Start date

2012-11-30

Completion date

2015-12-31

Last updated

2016-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

chronic obstructive pulmonary disease, Symbicort, long-term use

Brief summary

The purpose of the investigation is to confirm the safety and efficacy in long-term use of Symbicort Turbuhaler in patients with Chronic obstructive pulmonary disease (COPD) under the post-marketing actual use.

Detailed description

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for COPD patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Among patients treated with Symbicort Turbuhaler due to chronic obstructive pulmonary disease(COPD), those who received the drug for the first time.

Design outcomes

Primary

Measure	Time frame
Adverse event incidence	1 year

Secondary

Measure	Time frame
Clinical questionnaire about chronic obstructive pulmonary disease(CCQ)	At baseline, Week 12, Week 26, 1 year

Countries

Japan

Outcome results